Physician profile
Justina Tseng
NPI 1346276540
$2,954.17
in general payments reported to CMS, 2019-2025
16 companies · $327 in 2025
The $327 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2021: $173 · 2022: $1,184 · 2023: $411 · 2024: $690 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,428.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $638.08 | 2021-2025 | Rinvoq, Skyrizi |
| Amgen INC. | $443.84 | 2019-2025 | Enbrel, Krystexxa, Tavneos |
| Novartis Pharmaceuticals Corporation | $265.66 | 2022-2025 | |
| Pfizer INC. | $256.65 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $231.12 | 2022-2024 | Saphnelo |
| Horizon Therapeutics Plc | $180.04 | 2019-2022 | |
| Glaxosmithkline, LLC. | $178.11 | 2022 | |
| Mallinckrodt Hospital Products INC. | $163.26 | 2022 | |
| Organon LLC | $153.50 | 2023-2025 | Hadlima, Renflexis |
| Lilly USA, LLC | $126.30 | 2022-2025 | Taltz, Zepbound |
| Ucb, INC. | $107.84 | 2021-2025 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $76.66 | 2022-2024 | Orencia |
| Sobi, INC | $52.73 | 2024 | |
| Janssen Biotech, INC. | $33.67 | 2022-2023 | Simponi, Simponi Aria, Remicade |
| Genzyme Corporation | $27.20 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $19.51 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justina Tseng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.